Jade Biosciences Inc.

NASDAQ: JBIO · Real-Time Price · USD
7.33
0.56 (8.27%)
At close: Aug 15, 2025, 3:59 PM
7.30
-0.48%
After-hours: Aug 15, 2025, 07:20 PM EDT

Jade Biosciences Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
282K 96K 68K 15K
Gross Profit
-282K -96K -68K -15K
Operating Income
-71.08K -81.41M -53.24M -23.02M
Interest Income
5.04M 5.95M 1.83M 65K
Pretax Income
-93.96K -75.47M -51.49M -22.96M
Net Income
-93.96K -75.52M -51.51M -22.96M
Selling & General & Admin
8.61K 17.09M 14.55M 8.02M
Research & Development
62.47K 64.22M 38.62M 14.99M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
71.08K 81.31M 53.17M 23.01M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
71.08K 81.41M 53.24M 23.02M
Income Tax Expense
n/a 56K 25K 3K
Shares Outstanding (Basic)
5K 752.33K 699.2K 697.44K
Shares Outstanding (Diluted)
5K 752.33K 699.2K 697.44K
EPS (Basic)
-18.79 -100.38 -73.67 -32.96
EPS (Diluted)
-18.79 -100.38 -73.67 -32.96
EBITDA
n/a -75.37M -51.42M -22.95M
EBIT
-64.48K -75.47M -51.49M -22.96M
Depreciation & Amortization
64.48K 96K 68K 15K